NCT01050374View on ClinicalTrials.gov

Safety and Efficacy of Drug Combinations Against Schistosomiasis

NACompletedINTERVENTIONAL
Enrollment

650

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Parasitic Diseases
Interventions
DRUG

albendazole + praziquantel

albendazole (400 mg one dose) + praziquantel (40 mg/kg body weight)

DRUG

mebendazole + praziquantel

mebendazole (500 mg one dose) + praziquantel (40 mg/kg body weight)

Trial Locations (1)

Unknown

Vector Control Division, Kampala

All Listed Sponsors
lead

DBL -Institute for Health Research and Development

OTHER

NCT01050374 - Safety and Efficacy of Drug Combinations Against Schistosomiasis | Biotech Hunter | Biotech Hunter